What it's for (Indications)
- Aluminium hydroxide and magnesium trisilicate combination antacids are primarily indicated for the symptomatic relief of conditions associated with hyperacidity.
- These include dyspepsia (indigestion), heartburn (acid reflux), sour stomach, and other gastric discomforts often linked to excess stomach acid.
- They are commonly used to alleviate the symptoms of gastroesophageal reflux disease (GERD), peptic ulcer disease, and gastritis by neutralizing gastric acid, thereby reducing irritation of the esophageal and gastric mucosa.
- The combined formulation aims to provide rapid and sustained acid neutralization, helping to soothe burning sensations and discomfort experienced after meals or at night.
- This medication is intended for short-term use to manage acute symptoms rather than as a long-term therapeutic agent for underlying conditions.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of aluminium hydroxide and magnesium trisilicate typically varies based on the specific product formulation (e.g., suspension, chewable tablets) and the severity of symptoms. Generally, for adults and children over 12 years, the recommended dose is usually taken orally, between meals, at bedtime, or as needed for symptom relief. Common dosing regimens involve 10-20 mL of suspension or 1-2 chewable tablets four times a day. It is crucial to thoroughly chew tablets before swallowing or shake liquid suspensions well before use to ensure proper dispersion and efficacy. Patients should strictly adhere to the dosage instructions provided on the product label or as directed by a healthcare professional. Exceeding the recommended dose or duration of use, especially in individuals with renal impairment, can increase the risk of adverse effects such as electrolyte imbalances. Self-medication should not exceed two weeks without medical consultation. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated when used as directed, aluminium hydroxide and magnesium trisilicate can cause several side effects.
- The most common gastrointestinal disturbances reflect the individual properties of the components: aluminium hydroxide tends to be constipating, while magnesium trisilicate often has a laxative effect.
- This combination is designed to counteract these opposing effects, but individuals may still experience alterations in bowel habits, ranging from mild constipation to diarrhea.
- Other common side effects include chalky taste, stomach cramps, and nausea.
- More serious, though less frequent, adverse effects are typically associated with prolonged use or impaired renal function.
- These can include hypophosphatemia (due to aluminium's phosphate-binding capacity), hypermagnesemia (in patients with kidney dysfunction), and aluminium accumulation leading to bone or neurological issues.
- Any persistent or severe symptoms should prompt immediate medical evaluation.
Serious Warnings
- Black Box Warning: Antacid combinations such as aluminium hydroxide and magnesium trisilicate typically do not carry a formal FDA Black Box Warning. However, serious warnings are imperative for safe and effective use, particularly concerning specific patient populations and prolonged administration. Patients with pre-existing renal impairment are at significant risk for developing hypermagnesemia, characterized by symptoms such as hypotension, nausea, vomiting, central nervous system depression, and respiratory depression, due to impaired magnesium excretion. Furthermore, aluminium accumulation can occur in renal failure, potentially leading to aluminium osteodystrophy, encephalopathy, and microcytic anemia. Prolonged use of aluminium-containing antacids without phosphate supplementation can induce hypophosphatemia, a condition marked by muscle weakness, bone pain, and even rhabdomyolysis, necessitating careful monitoring, especially in malnourished individuals or those with malabsorption syndromes. Clinicians and patients must be vigilant regarding potential drug-drug interactions, as these antacids can significantly chelate or alter the absorption of numerous critical medications, including but not limited to tetracyclines, fluoroquinolones, iron supplements, and thyroid hormones, potentially reducing their therapeutic efficacy. Always consult a healthcare professional for use beyond short-term symptomatic relief or if underlying conditions exist.
- Patients should be advised of several important warnings associated with the use of aluminium hydroxide and magnesium trisilicate.
- This medication should not be used for more than two weeks, or if symptoms recur, without consulting a physician, as persistent symptoms may indicate a more serious underlying condition.
- Individuals with impaired renal function must exercise extreme caution, or avoid use altogether, due to the risk of magnesium accumulation leading to hypermagnesemia and aluminium accumulation causing toxicity.
- Concurrent use with other medications requires careful consideration as antacids can significantly interfere with the absorption of many drugs, including tetracyclines, fluoroquinolones (e.
- g.
- , ciprofloxacin, levofloxacin), iron preparations, certain antifungals (e.
- g.
- , ketoconazole), and thyroid hormones.
- It is advisable to administer these medications at least 2-4 hours apart from antacids.
- Prolonged use, particularly in the elderly or those with poor nutritional status, can lead to phosphate depletion.
- Pediatric use should be strictly under medical guidance.
How it Works (Mechanism of Action)
Aluminium hydroxide and magnesium trisilicate exert their therapeutic effect as antacids through a chemical neutralization reaction with gastric hydrochloric acid in the stomach. Aluminium hydroxide reacts with HCl to form aluminium chloride and water, thereby elevating the gastric pH. This reaction reduces the acidity of the stomach contents, which helps to alleviate symptoms of heartburn and indigestion. Aluminium hydroxide also possesses mild astringent properties and can cause constipation. Magnesium trisilicate, on the other hand, reacts with gastric acid to produce magnesium chloride, silicic acid, and water, similarly raising the pH. Magnesium salts are known for their osmotic laxative effect, which helps to counteract the constipating tendency of aluminium hydroxide, providing a more balanced effect on bowel function. The silicic acid formed may also contribute to a protective coating on the gastric mucosa. The combined action of these two inorganic salts provides rapid, effective, and sustained neutralization of gastric acid, leading to symptomatic relief.
Commercial Brands (Alternatives)
No other brands found for this formula.